Industry Should Outsource R&D To Manage Drug Development Costs, HGS CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Nearly all aspects of the drug development process can be done in other countries at substantial savings, Human Genome Sciences' Haseltine says. Outsourcing could reduce costs by up to two-thirds and allow greater flexibility, he maintains.